ART-104 (Arnatar Therapeutics)

N/A

Report date: 2025/09/17 11:04:17
NME

Base Information

Drug NameART-104 (Arnatar Therapeutics)
Drug Alias NameART-104ART104
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProtein jagged-1 modulators
TargetsProtein jagged-1
Therapy Area/IndicationsAlagille Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesSuzhou Arnatar Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Arnatar Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsAlagille Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A